SCH-50911 is a selective
GABAB antagonist.
Its main applications are in pharmacology research.
SCH-50911 also acts as an anticonvulsant under normal conditions. SCH-50911 induces acute withdrawal syndrome in GHB-dependent rats, similar to the
delirium tremens
Delirium tremens (DTs) is a rapid onset of confusion usually caused by withdrawal from alcohol. When it occurs, it is often three days into the withdrawal symptoms and lasts for two to three days. Physical effects may include shaking, shiver ...
seen in human
alcohol withdrawal, and can precipitate convulsions in GHB-dependent animals.
References
{{GABAergics
Antidotes
Carboxylic acids
GABAB receptor antagonists
Morpholines